Terms: = Cervical cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Treatment
10 results:
1. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells.
Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF
Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346
[TBL] [Abstract] [Full Text] [Related]
2. CircAGFG1 promotes cervical cancer progression via miR-370-3p/raf1 signaling.
Wu F; Zhou J
BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
[TBL] [Abstract] [Full Text] [Related]
3. Bag-1L is a stress-withstand molecule prevents the downregulation of Mcl-1 and c-raf under control of heat shock proteins in cisplatin treated HeLa cervix cancer cells.
Ozfiliz P; Arisan ED; Coker-Gurkan A; Obakan P; Eralp TN; Dinler-Doganay G; Palavan-Unsal N
Asian Pac J Cancer Prev; 2014; 15(11):4475-82. PubMed ID: 24969872
[TBL] [Abstract] [Full Text] [Related]
4. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract] [Full Text] [Related]
5. Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and c-raf.
Matsuzawa Y; Kiuchi Y; Toyomura K; Matsumoto I; Nakamura H; Fujino H; Murayama T; Kawashima T
J Pharmacol Sci; 2009 Oct; 111(2):182-92. PubMed ID: 19783865
[TBL] [Abstract] [Full Text] [Related]
6. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
[TBL] [Abstract] [Full Text] [Related]
7. Differential impact of raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
Britten RA; Klein K
Anticancer Drugs; 2000 Jul; 11(6):439-43. PubMed ID: 11001384
[TBL] [Abstract] [Full Text] [Related]
8. raf-1 kinase activity predicts for paclitaxel resistance in TP53mut, but not TP53wt human ovarian cancer cells.
Britten RA; Perdue S; Eshpeter A; Merriam D
Oncol Rep; 2000; 7(4):821-5. PubMed ID: 10854551
[TBL] [Abstract] [Full Text] [Related]
9. Paclitaxel is preferentially cytotoxic to human cervical tumor cells with low raf-1 kinase activity: implications for paclitaxel-based chemoradiation regimens.
Britten RA; Perdue S; Opoku J; Craighead P
Radiother Oncol; 1998 Sep; 48(3):329-34. PubMed ID: 9925253
[TBL] [Abstract] [Full Text] [Related]
10. High raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity.
Rasouli-Nia A; Liu D; Perdue S; Britten RA
Clin Cancer Res; 1998 May; 4(5):1111-6. PubMed ID: 9607567
[TBL] [Abstract] [Full Text] [Related]